Magangcong, Asnia P.

HRN: 27-44-83  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/08/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
01/08/2026
01/15/2026
IV
4.5g
Q8
UTI, IV Site Phlebitis, (DM Pt)
Checking Initial Appropriateness 

 Indication:  Empirical Escalation    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines